NCT01413490View on ClinicalTrials.gov

Hepatitis C Rimantadine and Antiviral Combination Therapy

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Hepatitis C
Interventions
DRUG

rimantadine

12 weeks of rimantadine therapy in addition to standard combination therapy with interferon and ribavirin

Trial Locations (1)

ls97tf

St James University Hospital, Leeds

Sponsors

Collaborators (1)

Cancer Research UK
All Listed Sponsors
collaborator

Cancer Research UK

OTHER

lead

The Leeds Teaching Hospitals NHS Trust

OTHER